| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,948,000 | 5,860,000 | 5,174,000 | | Cost of Revenue | 3,210,000 | 3,111,000 | 2,891,000 | | | Gross Profit | 2,738,000 | 2,749,000 | 2,283,000 | | | Operating Expenses | | Research Development | 627,000 | 565,000 | 517,000 | | Selling General and Administrative | 901,000 | 912,000 | 857,000 | | Non Recurring | (321,000) | 181,000 | 52,000 | | Others | 11,000 | 10,000 | 11,000 | | | | Total Operating Expenses | 1,218,000 | 1,668,000 | 1,437,000 | | | | Operating Income or Loss | 1,520,000 | 1,081,000 | 846,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 62,000 | 292,000 | 191,000 | | Earnings Before Interest And Taxes | 1,582,000 | 1,373,000 | 1,037,000 | | Interest Expense | 59,000 | 82,000 | 76,000 | | Income Before Tax | 1,523,000 | 1,291,000 | 961,000 | | Income Tax Expense | (2,405,000) | 80,000 | 55,000 | | Minority Interest | 1,000 | (3,000) | (11,000) | | | | Net Income From Continuing Ops | 5,257,000 | 2,150,000 | 1,855,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,257,000 | 2,150,000 | 1,855,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,257,000 | $2,150,000 | $1,855,000 |
|
0.16% Nasdaq 0.00%
Income Statement
